HSIC
50
2
JCI
57
2
AN
58
4
QRVO
9
-2
DUK
60
-4
PLD
56
13
AMP
73
3
FOXA
69
2
AIG
48
-8
SLB
55
2
HUM
33
3
PRGO
37
-3
VTR
60
5
HRB
32
-10
DHI
31
3
CTSH
54
2
LH
42
6
MCK
63
-3
NTAP
54
2
SE
82
3
HSIC
50
2
JCI
57
2
AN
58
4
QRVO
9
-2
DUK
60
-4
PLD
56
13
AMP
73
3
FOXA
69
2
AIG
48
-8
SLB
55
2
HUM
33
3
PRGO
37
-3
VTR
60
5
HRB
32
-10
DHI
31
3
CTSH
54
2
LH
42
6
MCK
63
-3
NTAP
54
2
SE
82
3
Financhill
Back

California Resources Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
15

CRC
California Resources

Last Price:
$48.24
Seasonality Move:
-7.14%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.31
Seasonality Move:
1.75%
Sell
15
California Resources (CRC) is a Sell

Is California Resources a Buy, Sell or Hold?

  • The current California Resources [CRC] share price is $48.23. The Score for CRC is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • CRC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRC Stock Price Chart

What is California Resources's stock price today?

  • The California Resources share price today is $48.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

CRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.56 Sell
Relative Strength Index (14 RSI): 42.04 Sell
Chaikin Money Flow: 760493 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.92 - 53.5) Sell
Bollinger Bands (100): (50.1 - 56.26) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

CRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.52 Buy
20-day SMA: 49.94 Sell
50-day SMA: 51.89 Sell
200-day SMA: 51.52 Sell
8-day EMA: 47.76 Buy
20-day EMA: 49.3 Sell
50-day EMA: 51.28 Sell
200-day EMA: 51.98 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

California Resources Earnings Growth & CRC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.97 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

California Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):